Table 3.
Nuclear AR and ERG Expression in Prostate Cancer
| Cohort | Diagnosis/Recurrence status | Core # | AR Mean OD ± SD | ERG mean OD ± SD |
|---|---|---|---|---|
| pTMA | Benign Prostate | 85 | 0.15 ± 0.06 | 0.06 ± 0.03 |
| HGPIN | 55 | 0.24 ± 0.07* | 0.13 ± 0.04* | |
| PCa, local | 81 | 0.26 ± 0.08* | 0.12 ± 0.05* | |
| PCa, aggressive | 61 | 0.24 ± 0.05* | 0.13 ± 0.04* | |
| Metastases | 41 | 0.29 ± 0.13* | 0.11 ± 0.06* | |
| oTMA | Benign Prostate | 73 | 0.19 ± 0.05 | 0.07 ± 0.03 |
| None | 226 | 0.27 ± 0.06* | 0.11 ± 0.05* | |
| Biochemical | 75 | 0.26 ± 0.06* | 0.10 ± 0.05* | |
| Cancer | 39 | 0.27 ± 0.06* | 0.09 ± 0.04* |
p < 0.01 compared to Benign Prostate;
Core #: number of cores analyzed; OD: optical density; SD: standard deviation.